QUÍMICA BIOLÓGICA APLICADA: NUEVOS FÁRMACOS Y BIORREMEDIACIÓN
QUIMBIO-F
Instituto Politécnico Nacional
Ciudad de México, MéxicoPublicaciones en colaboración con investigadores/as de Instituto Politécnico Nacional (8)
2023
-
Cytotoxic evaluation of YSL-109 in a triple negative breast cancer cell line and toxicological evaluations
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 396, Núm. 6, pp. 1211-1222
2022
-
In silico design of HDAC6 inhibitors with neuroprotective effects
Journal of Biomolecular Structure and Dynamics, Vol. 40, Núm. 24, pp. 14204-14222
-
Targeting Several Biologically Reported Targets of Glioblastoma Multiforme by Assaying 2D and 3D Cultured Cells
Cellular and Molecular Neurobiology, Vol. 42, Núm. 6, pp. 1909-1920
2021
-
Modifications on the tetrahydroquinoline scaffold targeting a phenylalanine cluster on GPER as antiproliferative compounds against renal, liver and pancreatic cancer cells
Pharmaceuticals, Vol. 14, Núm. 1, pp. 1-19
2020
-
Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines
Scientific Reports, Vol. 10, Núm. 1
-
O-Alkyl Hydroxamates Display Potent and Selective Antileishmanial Activity
Journal of Medicinal Chemistry, Vol. 63, Núm. 11, pp. 5734-5751
2017
-
Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations
Journal of Biomolecular Structure and Dynamics, Vol. 35, Núm. 13, pp. 2794-2814
2014
-
Exploring the potential binding sites of some known HDAC inhibitors on some HDAC8 conformers by docking studies
Applied Biochemistry and Biotechnology, Vol. 173, Núm. 7, pp. 1907-1926